MedTrace Logo

Treatment of Refractory Status Epilepticus

NCT00265616 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2013-04-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether propofol or barbiturates should be preferred in the treatment of status epilepticus (continuous seizure activity) refractory to 2 standard antiepileptic agents.

Conditions

  • Status Epilepticus

Interventions

DRUG

propofol

liquid, mg/kg.h, titrated after EEG

DRUG

thiopental/pentobarbital

liquid, mg/kg.h, titrated after EEG

Sponsors & Collaborators

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Andrea O. Rossetti, MD · BrighamHospital/CHUV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00265616 on ClinicalTrials.gov